Skip to main content

Exact Sciences buys biotech to advance multi-cancer test goal

Madison-based cancer diagnostics company Exact Sciences Corp. has purchased OmicEra Diagnostics, a German startup specializing in proteomics, or large-scale protein analysis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.